FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and medicine, namely a stable pharmaceutical composition of a water-soluble salt of vinorelbine. The composition contains approximately 56 wt % of a diluent, approximately 2.5 wt % of a binding agent, approximately 5 wt % of a disintegrant, approximately 0.25 wt % of a flow agent and approximately 0.5 wt % of a lubrication agent. The water-soluble salt of vinorelbine is preferentially vinorelbine ditartrate.
EFFECT: pharmaceutical composition is preferentially presented in the form of a gelatine capsule or a tablet.
5 cl, 6 ex, 12 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| STABLE PHARMACEUTICAL COMPOSITION CONTAINING WATER-SOLUBLE VINFLUNINE SALT | 2008 |
|
RU2462248C2 |
| NEW COMPOSITION OF LAPATINIB AS A SOLID DOSAGE FORM FOR ORAL USE AND A METHOD OF ITS MANUFACTURE | 2019 |
|
RU2821950C2 |
| SOLID DOSAGE FORMS OF PALLBOCYCLOB | 2016 |
|
RU2686840C1 |
| LENALIDOMIDE TABLET COMPOSITION FOR ORAL ADMINISTRATION | 2017 |
|
RU2725074C1 |
| DOSAGE FORMS FOR ORAL APPLICATION CONTAINING LICARBAZEPINE ACETATE | 2008 |
|
RU2546521C2 |
| DRY GRANULATION PROCESS FOR PRODUCING TABLET COMPOSITIONS OF METFORMIN AND COMPOSITIONS THEREOF | 2013 |
|
RU2647421C2 |
| PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN LOBEGLITAZONE FOR ORAL ADMINISTRATION | 2015 |
|
RU2709526C2 |
| STABLE PHARMACEUTICAL PREPARATION CONTAINING AMLODIPINE BENZYLATE AND ATENOLOL | 1998 |
|
RU2188636C2 |
| MEDICAL USE OF PYRROLOPYRIMIDINE COMPOUND AND SOLID PHARMACEUTICAL COMPOSITION OF PYRROLOPYRIMIDINE COMPOUND | 2019 |
|
RU2810112C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING DORAVIRINE, TENOFOVIR DISOPROXIL FUMARATE AND LAMIVUDINE | 2016 |
|
RU2736941C2 |
